메뉴 건너뛰기
Aviation Space and Environmental Medicine
Volumn 77, Issue 7, 2006, Pages 742-744
Acute mountain sickness and ascent rates in trekkers above 2500 m in the Nepali Himalaya
Author keywords

Altitude sickness; AMS; HACE; HAPE; High altitude medicine
Indexed keywords

ACETAZOLAMIDE;
EID: 33745944852     PISSN: 00956562     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (52)
References (9)
  • 2
    • 0032744418 scopus 로고    scopus 로고
    • Everest or bust: A cross sectional, epidemiological study of acute mountain sickness at 4243 meters in the Himalayas
    • Basnyat B, Lemaster J, Litch J. Everest or bust: a cross sectional, epidemiological study of acute mountain sickness at 4243 meters in the Himalayas. Aviat Space Environ Med 1999; 70: 867-73.
    • (1999) Aviat Space Environ Med , vol.70 , pp. 867-873
    • Basnyat, B.1    Lemaster, J.2    Litch, J.3
  • 3
    • 0032759148 scopus 로고    scopus 로고
    • Trends in the workload of the two high altitude aid posts in the Nepal Himalayas
    • Basnyat B, Savard GK, Zafren K. Trends in the workload of the two high altitude aid posts in the Nepal Himalayas. J Travel Med 1999; 6:217-22.
    • (1999) J Travel Med , vol.6 , pp. 217-222
    • Basnyat, B.1    Savard, G.K.2    Zafren, K.3
  • 4
    • 84944369037 scopus 로고
    • Impaired osmoregulation at high altitude. Studies on Mt Everest
    • Blume FD, Bover SJ, Braverman LE, et al. Impaired osmoregulation at high altitude. Studies on Mt Everest. JAMA 1984; 252:524-6.
    • (1984) JAMA , vol.252 , pp. 524-526
    • Blume, F.D.1    Bover, S.J.2    Braverman, L.E.3
  • 5
    • 1842506452 scopus 로고    scopus 로고
    • Randomised, double blind, placebo controlled comparison of ginkgo biloba and acetazolamide for prevention of acute mountain sickness among Himalayan trekkers: The prevention of high altitude illness trial (PHAIT)
    • Gertsch JH, Basnyat B, Johnson EW, et al. Randomised, double blind, placebo controlled comparison of ginkgo biloba and acetazolamide for prevention of acute mountain sickness among Himalayan trekkers: the prevention of high altitude illness trial (PHAIT). Br J Med 2004; 328:797.
    • (2004) Br J Med , vol.328 , pp. 797
    • Gertsch, J.H.1    Basnyat, B.2    Johnson, E.W.3
  • 6
    • 0017109687 scopus 로고
    • The incidence, importance and prophylaxis of acute mountain sickness
    • Hackett PH, Rennie D. The incidence, importance and prophylaxis of acute mountain sickness. Lancet 1976; 2:1149-55.
    • (1976) Lancet , vol.2 , pp. 1149-1155
    • Hackett, P.H.1    Rennie, D.2
  • 7
    • 0032495880 scopus 로고    scopus 로고
    • Acute mountain sickness in the Southern Alps of New Zealand
    • Murdoch DR, Curry C. Acute mountain sickness in the Southern Alps of New Zealand. NZMJ 1998; 111:168-9.
    • (1998) NZMJ , vol.111 , pp. 168-169
    • Murdoch, D.R.1    Curry, C.2
  • 8
    • 0036899760 scopus 로고    scopus 로고
    • Acute mountain sickness: Influence of susceptibility, preexposure and ascent rate
    • Schnieder M, Bernasch D, Weymann J, et al. Acute mountain sickness: influence of susceptibility, preexposure and ascent rate. MSSE 2002; 34:1886-91.
    • (2002) MSSE , vol.34 , pp. 1886-1891
    • Schnieder, M.1    Bernasch, D.2    Weymann, J.3
  • 9
    • 0035257866 scopus 로고    scopus 로고
    • Acute mountain sickness at 3500 and 4250 m. A study of symptom incidence and severity
    • Vargas M, Osorio J, Jimenez D, et al. Acute mountain sickness at 3500 and 4250 m. A study of symptom incidence and severity. Rev Med Chile 2001; 129:166-72.
    • (2001) Rev Med Chile , vol.129 , pp. 166-172
    • Vargas, M.1    Osorio, J.2    Jimenez, D.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.